-
Product Name
p38 MAPK antibody
- Documents
-
Description
p38 MAPK Mouse Monoclonal antibody. Positive WB detected in human heart tissue, pig heart tissue. Observed molecular weight by Western-blot: 38-42 kDa
-
Tested applications
ELISA, WB
-
Species reactivity
Human, Pig; other species not tested.
-
Alternative names
CSAID binding protein antibody; CSBP antibody; CSBP1 antibody; CSBP2 antibody; CSPB1 antibody; EXIP antibody; MAP kinase 14 antibody; MAP kinase MXI2 antibody; MAP kinase p38 alpha antibody; MAPK 14 antibody; MAPK14 antibody; MAX interacting protein 2 antibody; Mxi2 antibody; p38 antibody; p38 MAPK antibody; p38ALPHA antibody; PRKM14 antibody; PRKM15 antibody; SAPK2A antibody
-
Isotype
Mouse IgG2b
-
Preparation
This antibody was obtained by immunization of p38 MAPK recombinant protein (Accession Number: NM_139012). Purification method: Protein A purified.
-
Clonality
Monoclonal
-
Formulation
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:1000-1:10000
-
Validations
human heart tissue were subjected to SDS PAGE followed by western blot with Catalog No:107443(p38 MAPK Antibody) at dilution of 1:2000
-
Background
MAPK14(mitogen-activated protein kinase 14) is also named as SAPK2A, p38MAPK, CSBP1, RK, p38, EXIP, Mxi2, CSBP2, PRKM14, PRKM15, CSPB1, p38ALPHA and belongs to the MAP kinase subfamily. MAPK14-signaling is a central pathway for the integration of instructive signals in dendritic cells for T(H)17 differentiation and inflammation(PMID:22231518). It plays an important role in the regulation of hematopoietic stem cellself-renewal in vitro and inhibition of MAPK14 activation with a small molecule inhibitor may represent a novel approach to promote ex vivo expansion of hematopoietic stem cell(PMID:21198398). This protein has 4 isoforms produced by alternative splicing.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"